Subcutaneous Olanzapine at the End of Life in a Patient with Schizophrenia and Dysphagia
Currently, there is a paucity of evidence to guide the management of antipsychotic therapy at the end of life for patients with schizophrenia. A 51-year-old female with a diagnosis of palliative squamous cell carcinoma of the tonsils was admitted to her local hospice for end-of-life care. She had a...
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Mary Ann Liebert
2020-06-01
|
| coleção: | Palliative Medicine Reports |
| Assuntos: | |
| Acesso em linha: | https://www.liebertpub.com/doi/full/10.1089/PMR.2020.0039 |